840485C

18:2 PG

1,2-dilinoleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt), chloroform

• Synonym(e): 1,2-di-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-(1′racglycerol) (sodium salt); PG(18:2(9Z,12Z)/18:2(9Z,12Z))
• Empirische Formel (Hill-System): C₄₂H₇₄O₁₀PNa
• CAS-Nummer: 322729-38-4
• Molekulargewicht: 792.99
• UNSPSC-Code: 51191904
• NACRES: NA.25

Eigenschaften

• Assay: >99% (TLC)
• Form: liquid
• Verpackung: pkg of 1 × 2.5 mL (840485C-25mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 840485C
• Konzentration: 10 mg/mL (840485C-25mg)
• Lipid-Typ: cardiolipins; phospholipids
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• InChI: 1S/C42H75O10P.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-41(45)49-37-40(38-51-53(47,48)50-36-39(44)35-43)52-42(46)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;/h11-14,17-20,39-40,43-44H,3-10,15-16,21-38H2,1-2H3,(H,47,48);/q;+1/p-1/b13-11-,14-12-,19-17-,20-18-;/t39?,40-;/m1./s1
• InChIKey: ZIOOVFPFWVCCEB-WDFQPZSRSA-M

Beschreibung

Allgemeine Beschreibung

18:2 PG or 1,2-dilinoleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) is a sodium salt of glycerophospholipid, with substitution of two chains of linolenic acid at the sn-1 and sn-2 positions and phospho-(1′-rac-glycerol) at the sn-3 position of the glycerol backbone. It is a poly-unsaturated lipid molecule.

Anwendung

18:2 PG or 1,2-dilinoleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt) might be used in saposin-derived lipid nanoparticles (SapNPs) formation to study the lipid specificity of saposins.

Verpackung

5 mL Clear Glass Sealed Ampule (840485C-25mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Piktogramme: GHS06,GHS08
• Signalwort: Danger
• H-Sätze: H302,H315,H319,H331,H336,H351,H361d,H372
• P-Sätze: P201 - P260 - P264 - P280 - P304 + P340 + P311 - P403 + P233
• Gefahreneinstufungen: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• Zielorgane: Central nervous system
• WGK: WGK 3